All content for iMedicus Cardiology is the property of imedicuscardiology and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Updates to the CCS Dyslipidemia Guidelines: Application to Established CVD Patients
iMedicus Cardiology
15 minutes 8 seconds
4 years ago
Updates to the CCS Dyslipidemia Guidelines: Application to Established CVD Patients
In this podcast, we are joined by Dr. Vineeta Ahooja, cardiologist in the greater Toronto area at the Heart Health Institute, and Dr. George Thanassoulis, cardiologist at McGill University Health Centre and Co-Chair of the 2021 Canadian Cardiovascular Society Dyslipidemia Guidelines. They discuss the use of ezetimibe and PCSK9i, including considerations around the costs of medications. When triglycerides are high, should icosapent ethyl or PCSK9i be considered first? Listen to find out!
This program was made available through funding from HLS Therapeutics.
